50 employees
Base Genomics is an epigenetics company focusing on developing a blood test for early-stage cancer and minimal residual disease.
2019
$11M
from 1 investors over 1 rounds
Base Genomics raised $11M on June 3, 2020
Investors: Oxford Sciences Innovation